microsoft word - preprint system immunolog lead tuberculosi eradication? perejoan cardona1*, mart catal2, marta arch1, lilibeth arias1, sergio alonso2, paula cardona1, daniel lpez2, cristina vilaplana1, clara prats2* 1 unitat tuberculosi experimental, fundaci institut dinvestigaci en cinci la salut german tria pujol, universitat autnoma barcelona, ciberes, badalona, catalonia. spain. 2 departa fsica, universitat politcnica catalunyabarcelonatech, castelldefels, catalonia, spain. *correspond authors: perejoan cardona clara prat abstract (100120 words) 25 year declar global emerg world health organization, tuberculosi (tb) remain major enemi humankind. period, progress better understand natur history, reveal huge complexity, highlight need implement system immunolog approaches. recent advanc focus understand role macrophag subtyp dendrit cell role, import cytokin balance, antigen repertoire. identif earli irrupt polymorphonuclear neutrophil extracellular growth bacilli disrupt factor understand evolut activ tb. inclus futur model provid new tool better understand tuberculosis. keyword system biology, system immunology, tuberculosis, granuloma, mathemat model, agentbas model. introduct mycobacterium tuberculosi (mtb) remain bacteria abl caus highest mortal itself. tuberculosi (tb) natur histori extraordinari complex and, fact, unknown [1] mechan underli it. signific increas new inform year entranc omics, remain unclear interpret us inform understand kei questions. review tb faq [2] clear strong declar humil issue, show degre ignor immers 1993, world health organ declar time histori global emerg link sole infecti disease. lack knowledg capabl give respons question explan current feel trap immerse, extrem asham publicli declar search pink swan [3]. number crush global annual stabil absolut number new tb case (around 9 million), massiv death (around 1.4 million), increas multidrugresist case (about 0.5 million), slow annual decreas incid (around 1.5%) and, worse, clear understand data come epidemiolog model [4]. scenario clear contrast with, instance, recent success achiev case ebola. roughli 3 year epidem declar occident africa, vaccin avail give 100% efficaci protect [5]. purpos work obtain thorough understand 14 biolog phenomena identifi cellular level system immunolog approach enabl contextu quantifi time/spati frame. provid better knowledg natur histori mtb infect facilit progress fight tb. role look tb challeng point view silico system immunology? usually, system immunolog approach seen skeptic immens major researchers. complex mathemat languag theoret assumpt help understand valu experiment researchers. try set multidisciplinari team [6], intellectu background integr usual repres strong handicap fluent exchang ideas. addition, differ interests. side, experiment research want new clue predict work. side, theoret biologist need new experiment data confirm models. all, basic point confluenc help sides: try includ experiment observ relev time space frame. system immunolog right approach bridg issu context host pathogen interact infecti diseases, defend kirschner et al [7]. general, comput model offer platform experiment data integr interpret observ phenomena. addition, carefulli design simul seri appropri test hypothesis, explor paramet space higher precis wider rang experiments, predict emerg behaviors. system immunolog substitut experiment observations, perfect travel companion face tb challeng level. bottomlin system biologi approach davi et al. [6] defin system approach broad strategi understand complex set interact compon work produc certain outcomes, give rise system immunolog deal interact compon immun system. system immunolog approach us differ model techniques, take consider common characterist biosystem aim describe: (1) constitut discret elements, chemic signal molecular structur cellular membran popul cell organ certain structures; (2) behavior stochast elements; (3) normal necessari consid spacetim framework order understand dynamics. continu model approxim part compon discret element relevant. contrary, bottomup approach necessari deal interact components, agentbas models, multiscal approach hybrid model reveal strateg interesting. gransim: histor hybrid system immunolog approach granuloma format gransim hybrid model granuloma dynam releas 2004 segoviajuarez et al [8]. origin version, combin continu model chemokin discret agent approach macrophag t cell cellular automatalik environment. hybrid model experienc subsequ modif updat deal particular questions, detail follow section, group tool simul tb hostpathogen interact lungs. reason tb morpholog model. set basic phenotyp spacetim frame. main driver immun respons tb cellular immun response, logic draw cellular scale. figur 1 tri roughli includ progress 14 step taken account system biologi approach understand disease. paragraph look differ steps, revis recent system biologi approach highlight unknown need tackled. tabl 1 summar publish approach relat correspond step (1 14), provid technic detail kind model(s) used, us gransim not, main purpos variabl considered. long road alveoli (1) step entranc bacilli aerosol drop. step consid scope review, lack understand make worthi consid it, especi take account data recent appear role hydrophob cell wall mtb comparison mycobacteria influenc remain aerosol droplet [9]. also, newest data aerosol qualiti capac aerosol hold mtb bacillari clump [10] relev understand interact alveolar macrophage. stage, need link classic data frequent observ tb right upper lobe peripheri lung [11] respiratori movement bronchial tree geometry, take advantag newest data deposit particl help virtual model lung [12]. interact alveoli (2) lot inform interact mtb alveolar macrophag (am), rel easi model vitro. nevertheless, model integr interact receptor escap mtb phagosom trigger necrot factor inhibit apoptot ones, built yet. equally, level, interact epitheli cell macrophag destroi growth bacilli clarifi [13]. regard, drosophila melanogast appear good model clarifi interact bacilli respiratori intestin epithelia [14]. new recent model built netlogo platform link lack drainag alveoli upper lobe local accumul bacilli. increas bacillari charg face new incom alveolar macrophage, link type inflammatori respons (i.e., monocyt polymorphonuclear neutrophil (pmn) oriented) [15]. onset granuloma (3&4) assum alveolu hold uniqu replac physiolog phenomenon. phagocyt particl pathogen carri inhal air. thus, substitut consid normal. thought that, sort interact epitheli cells, interstiti on replac damag am. import point order tight alveoli disrupt low tension surfac induc constant secret surfact avoid collapse. trigger local inflammatori respons break endotheli integr allow entranc blood cell plasma understood process. tune repres loss alveoli functionality. probabl take place neighbor acini (for anatom reasons) necrot [3]. local accumul chemokines, sure help stimul epitheli cells, lead critic point stimul entranc blood cell plasma, ruin acini. mention above, inflammatori respons induc sort granulomas, monocyt predomin (proliferative) pmn base (exudative). phenomenon recent defin carefulli studi murin model c3heb/fej strain, known kramnik model [16], [17]. monocyt infiltr transform macrophages, differenti m1 m2 class, fact relev differenti capac react bacilli, recent point mathemat model [18]. interact region lymph node (5) inflammatori respons destruct alveoli functionality, lymphat drainag start propel overpressur caus plasmat entrance. bacilli drain freeli local lymph node beginning, newli induc dendrit cell (dc) afterwards. there, phagocytos line macrophag dispos narrow subcapsular sinu [19]. filter final phagocytos dcs. aspect address experiment rais concept compart lymphat tissue: infect prolif one, respect [20], process merit deep model exercise. dc trigger lymphocyt prolifer depend inflammatori media immersed. acut mediators, complex mixtur il1, tnf, il6, il10, prostaglandin leukotriens, cite them, cytokin like il2, il4, il12, il13, ifn tgf determin sort cd4 t (th1, th2 th17 basically) cd8 t, treg b cells. complex process initi address constantli updat gransim model [8]. latest versions, multi compart hybrid model, explicitli account dc role interact region lymph node [21], [22]. updat rais select antigen select memori t cell abl better control infect [22]. relat granuloma adapt immun respons (6 8) sort lymphocyt popul trigger prolifer lymph node reach lung parenchyma, pump right ventricle. basically, th1 cell detect activ infect macrophag ifn kill bacilli. action induc cd8 cells. hand, action moder th2 cell induc il4 il10. treg help antiinflammatori respons secret il10 tgf direct cell cell interaction. equally, activ macrophag tend suppress action t cells, rais typic doughnut form, reproduc model [23], [24], abl stop local prolifer lymphocyt (if take places, controversi issue). activ macrophag hold surviv bacilli that, enter dormancy, avoid destruction. phagocyt cellular debri death cells, final foami macrophag (fm) [25]. fm local necrot drain bronchi escal [26]. case, trap parenchyma develop local new foci, reach drain alveolar fluid. th17 lymphocyt respons attract pmns. product highli bias initi induct pmnbase granuloma begin infection. enorm effort omic studi huge inform obtain it, come blood sampl human macaqu model, push new algorithm understand complex final includ model like gransim, constant updat new inform obtain [21], [24], [27][30]. balanc size granuloma (9) induct tb character format larg lesion abl seen chest x ray, i.e., 10 mm. recent data c3heb/fej show exponenti growth granuloma thank massiv infiltr pmn fuel extracellular growth bacilli sooner previou concept releg phenomenon liquefact cavit lesion [31]. phenomenon help drainag infect fm appear heavili surround pmns, push peripher growth lesion [16]. lead think coalesc lesion rais tb bubbl model [32], demonstr induct larg lesion requir exponenti growth lesion (a seen infiltr pmns), constant induct peripher daughter new foci, confluenc lesions. import factor, usual pmn role tb granuloma addressed, gransim model [8] system biologi approach [18], [23], [33], [34], consid unknown role cells, includ assumptions. interestingly, data human lesion obtain preantibiot era, clearli point presenc sort lesions: prolif ones, control size encapsulated, macrophagebased; exud ones, predominium pmns, on enlarge, liquefact cavitated, develop larg pneumon processes, characterist lesion activ tb [15]. new tool like monitor lesion macaqu model thank tacpet [35] definit help understand growth process lesions. fact, us mtb barcod strain clear clue [36]. encapsul process (10) growth lesion physic constraint, interlobular septa divid lung parenchyma [37]. describ minipig model [38], take place mice lesion touch pleura. role fibroblast balanc anti inflammatori immun respons (both trigger th2 treg cells) help encapsulation, induct miofibroblast control size lesion. role tgf fibrosi recent address gransim model [28], encapsul process explor model perspect [15]. airwai drainag bacilli, wai gastrointestin parenchyma (11 12) thank bronchial drainag fm, bacilli opportun reach alveolar fluid. drain gastrointestin tract. actually, wellknown wai diagnos tb children, develop cavit lesions, gastric lavage. however, bacilli aerosol induc final bronchi, thank constant expans retract respiratori movements. experiment data model aspect, integr deeper model better understand aerosol movement lung, point above. barcod mtb strain [36] clearli clue it. wai alveoli capillari net (13) bacilli reach lymph node reason predict escap macrophag dcs, effer vessel reach cava vein, right auricl ventricle, pump lung parenchyma. case possibl reach previous infect foci higher, higher irrigation. phenomenon highlight zebra fish model [39], actual relev probabl bacilli induc new foci clarifi yet. logic suppos clump bacilli better chanc induc blockag capillari end, disrupt endotheli parenchyma enter alveoli seen experiment [40]. remain bacilli reach left ventricl induc extrapulmonari lesions. second system wave (14) consolid granulomas, especi enlarg ones, new process place. progress format necrosi appear hypox zones. aspect address model understand mode action chemotherapi [23], [34], [41]. import process neo vascularization. special fragility, facilit direct entranc bacilli blood extrapulmonari distribut left ventricle. discuss 2004, build gransim tb model group kirschner [8], understand natur histori tb experi new impulse. years, group greatli updat includ role cytokines, dc fibroblasts. expect includ pmns, local dissemin lesion encapsul process order better model. gransim system biologi approach great progress understand state 14 steps, summar tabl 1. furthermore, import build new model better understand dynam infect aerosol possibl bacillu entranc capillari net reach extrapulmonari sites. conclus identif earli irrupt pmn extracellular growth bacilli disrupt factor understand evolut activ tb appear years. incorpor current model sure hallmark understand progress activ tb provid new tool fight it. acknowledg plan nacion i+d+i cofinanc isciiisubdireccin gener evaluacin fondoeu desarrollo region (feder) cofund project pi11/01702, pi14/01038 ms 13/00174, ramon y cajal program grant ryc201211265, contract cp13/00174 ifi14/00015. centro investigacin biomdica en red enfermedad respiratoria (ciberes). experiment tuberculosi unit accredit catalan agenc manag univers research grant code 2017 sgr500 igtp member cerca network institutes. funder role studi design, data collect analysis, decis publish, prepar manuscript. jlia gallardo, draw excel figure! refer [1] t.h.m. ottenhoff, known unknown immunopathogenesi tuberculosis, int. j. tuberc. lung dis., vol. 16, no. 11, pp. 14241432, 2012. [2] k. m. guinn e. j. rubin, tuberculosis: faqs, mbio, vol. 8, no. 6, pp. 1 14, 2017. [3] p.j. cardona, learn miss tuberculosi pathophysiolog new vaccin design: search pink swan, front. immunol., vol. 8, no. may, p. 556, 2017. [4] world health organization, global tuberculosi report 2017. geneva, switzerland: who, 2017. [5] f. a. plummer s. m. jones, stori canada ebola vaccine, c. can. med. assoc. j., vol. 189, no. 43, pp. e1326e1327, oct. 2017. [6] m. m. davis, c. m. tato, d. furman, system immunology: get started, nat. immunol., vol. 18, no. 7, pp. 725732, 2017. [7] d. kirschner, e. pienaar, s. marino, j.j. linderman, review comput mathemat model contribut understand mycobacterium tuberculosi withinhost infect treatment, curr. opin. syst. biol., vol. 3, pp. 170185, 2017. [8] j. l. segoviajuarez, s. ganguli, d. kirschner, identifi control mechan granuloma format m. tuberculosi infect agentbas model., j. theor. biol., vol. 231, no. 3, pp. 35776, dec. 2004. [9] m. jankute, v. nataraj, o. y. c. lee, h. h. t. wu, m. ridell, n. j. garton, m. r. barer, d. e. minnikin, a. bhatt, g. s. besra, role hydrophob tuberculosi evolut pathogenicity, sci. rep., vol. 7, no. 1, p. 1315, 2017. [10] r. wood, c. morrow, c. e. barry, w. a. bryden, c. j. call, a. j. hickey, c. e. rodes, t. j. scriba, j. blackburn, c. issarow, n. mulder, j. woodward, a. moosa, v. singh, v. mizrahi, d. f. warner, realtim investig tuberculosi transmission: develop respiratori aerosol sampl chamber (rasc), plo one, vol. 11, no. 1, p. e0146658, jan. 2016. [11] j. f. murray, structur function lung, int. j. tuberc. lung dis., vol. 14, no. 4, pp. 391396, 2010. [12] s. miyawaki, e. a. hoffman, c.l. lin, effect static vs. dynam imag particl transport ctbase numer model human central airways, j. aerosol sci., vol. 100, pp. 129139, oct. 2016. [13] m. cantone, g. santos, p. wentker, x. lai, j. vera, multipl mathemat model strategi search molecular cellular insight bacteria lung infection, front. physiol., vol. 8, no. aug, 2017. [14] h. s. jin, h.m. lee, d.h. lee, g.h. cha, k. s. cho, j. jang, e.k. jo, function characteris drosophila cg6568 gene host defenc mycobacterium marinum, microb infect., vol. 19, no. 6, pp. 351357, jun. 2017. [15] p.j. cardona c. prats, small breath amplitud upper lobe favor attract polymorphonuclear neutrophil mycobacterium tuberculosi lesion help understand evolut activ diseas individualbas model, vol. 7, p. 354, 2016. [16] e. marzo, c. vilaplana, g. tapia, j. diaz, v. garcia, p.j. cardona, damag role neutrophil infiltr mous model progress tuberculosis., tuberculosis, vol. 94, no. 1, pp. 5564, jan. 2014. [17] i. kramnik g. beamer, mous model human tb pathology: role analysi necrosi develop hostdirect therapies, semin. immunopathol., vol. 38, no. 2, pp. 221237, 2016. [18] w. hao, l. s. schlesinger, a. friedman, model granuloma respons infect lung, plo one, vol. 11, no. 3, p. e0148738, mar. 2016. [19] e. e. grai j. g. cyster, lymph node macrophages, j. innat immun., vol. 4, no. 56, pp. 424436, 2012. [20] c. vilaplana, c. prats, e. marzo, c. barril, m. vegu, j. diaz, j. valls, d. lpez, p.j. cardona, achiev earlier ifn respons suffici control mycobacterium tuberculosi infect mice., plo one, vol. 9, no. 6, p. e100830. [21] s. marino d. kirschner, multicompart hybrid comput model predict kei role dendrit cell tuberculosi infection, computation, vol. 4, no. 4, p. 39, oct. 2016. [22] c. ziraldo, c. gong, d. e. kirschner, j. j. linderman, strateg prime multipl antigen yield memori cell phenotyp optim infect mycobacterium tuberculosis: comput study, front. microbiol., vol. 6, no. jan, pp. 121, 2016. [23] c. l. sershen, s. j. plimpton, e. e. may, oxygen modul effect granuloma mediat host respons mycobacterium tuberculosis: multiscal comput biologi approach, front. cell. infect. microbiol., vol. 6, no. february, pp. 125, 2016. [24] s. marino, h. p. gideon, c. gong, s. mankad, j. t. mccrone, p. l. lin, j. j. linderman, j. a. l. flynn, d. e. kirschner, comput empir studi predict mycobacterium tuberculosisspecif t cell biomark infect outcome, plo comput. biol., vol. 12, no. 4, pp. 130, 2016. [25] n. cceres, g. tapia, i. ojanguren, f. altare, o. gil, s. pinto, c. vilaplana, p.j. cardona, evolut foami macrophag pulmonari granuloma experiment tuberculosi models., tuberculosi (edinb)., vol. 89, no. 2, pp. 17582, mar. 2009. [26] d. g. russell, p.j. cardona, m.j. kim, s. allain, f. altare, foami macrophag progress human tuberculosi granuloma, nat. immunol., vol. 10, no. 9, pp. 943948, sep. 2009. [27] h. c. warsinske, e. pienaar, j. j. linderman, j. t. mattila, d. e. kirschner, delet tgf1 increas bacteri clearanc cytotox t cell tuberculosi granuloma model, front. immunol., vol. 8, no. dec, 2017. [28] h. c. warsinske, r. m. difazio, j. j. linderman, j. a. l. flynn, d. e. kirschner, identifi mechan drive format granulomaassoci fibrosi mycobacterium tuberculosi infection, j. theor. biol., vol. 429, pp. 117, 2017. [29] e. pienaar, w. m. matern, j. j. linderman, j. s. bader, d. e. kirschner, multiscal model mycobacterium tuberculosi infect map metabolit gene perturb granuloma steril predictions, infect. immun., vol. 84, no. 5, pp. 16501669, 2016. [30] e. a. wong, l. joslyn, n. l. grant, e. klein, p. l. lin, d. e. kirschner, j. l. flynn, low level t cell exhaust tubercul lung granulomas., infect. immun., no. june, p. iai.0042618, 2018. [31] j. grosset, mycobacterium tuberculosi extracellular compartment: underestim adversary, antimicrobi agent chemotherapy, vol. 47, no. 3, pp. 833836, 2003. [32] c. prats, c. vilaplana, j. valls, e. marzo, p.j. cardona, d. lpez, local inflammation, dissemin coalesc lesion kei progress activ tuberculosis: bubbl model, front. microbiol., vol. 7, no. february, p. 33, 2016. [33] e. ibargenmondragn, l. esteva, e. m. burbanorosero, mathemat model growth mycobacterium tuberculosi granuloma, math. biosci. eng., vol. 15, no. 2, pp. 407428, 2017. [34] r. bowness, m. chaplain, g. powathil, s. gillespie, model effect bacteri cell state spatial locat tuberculosi treatment: insight hybrid multiscal cellular automaton model, j. theor. biol., vol. 446, pp. 87100, 2018. [35] p. l. lin, p. maiello, h. p. gideon, m. t. coleman, a. m. cadena, m. a. rodgers, r. gregg, m. omalley, j. tomko, d. fillmore, l. j. frye, t. rutledge, r. m. difazio, c. janssen, e. klein, p. l. andersen, s. m. fortune, j. a. l. flynn, pet ct identifi reactiv risk cynomolgu macaqu latent m. tuberculosis, plo pathog., vol. 12, no. 7, pp. 117, 2016. [36] c. j. martin, a. m. cadena, v. w. leung, l. lin, p. maiello, n. hicks, m. r. chase, j. l. flynn, digit barcod mycobacterium tuberculosi reveal vivo infect dynam macaqu model tuberculosis, mbio, vol. 8, pp. e0031217, 2017. [37] p.j. cardona, kei role exud lesion encapsulation: lesson learn patholog human pulmonari tuberculosis., front. microbiol., vol. 6, p. 612, jan. 2015. [38] o. gil, i. daz, c. vilaplana, g. tapia, j. daz, m. fort, n. cceres, s. pinto, j. cayl, l. corner, m. domingo, p.j. cardona, granuloma encapsul kei factor contain tuberculosi infect minipigs., plo one, vol. 5, no. 4, p. e10030, jan. 2010. [39] m. r. cronan d. m. tobin, fit consumption: zebrafish model tuberculosis., dis. model. mech., vol. 7, no. 7, pp. 77784, jul. 2014. [40] n. cceres, i. llopis, e. marzo, c. prats, c. vilaplana, d. g. viedma, s. samper, d. lpez, p.j. cardona, low dose aerosol fit innat phase murin infect better predict virul clinic strain mycobacterium tuberculosis, plo one, vol. 7, no. 1, p. e29010, jan. 2012. [41] m. datta, l. e. via, w. chen, j. w. baish, l. xu, c. e. barry, r. k. jain, mathemat model oxygen transport tuberculosi granulomas, ann. biomed. eng., vol. 44, no. 4, pp. 863872, 2016. figur 1. fourteen step frame mycobacterium tuberculosi immunemodel long road alveoli (1). interact alveoli (2). onset granuloma, depend infiltr percentag pmn identifi prolif (3) exud (4) low high, respectively. interact region lymph node (5). adapt immun trigger control bacillari load case prolif granuloma thank predominium th1 respons (6 8) progress increas thank enhanc entranc pmn allow extracellular growth bacilli (7 9). prolif lesion rapidli encapsul (10). lesion constant drainag dormant bacilli carri foami macrophag bronchial tree (11) majoritarili drain gastrointestin tract (12) reenter lung parenchyma (1). system reinfect infect lymph node, drain right heart pump lung (13), directli lesions, reach left heart abl induc extrapulmonari lesion (14). tabl 1: review system biologi approach understand tbrelat issu period 20162018 model type us gransim (yes/no) main purpos main variabl step totally/parti consid model* refer agentbas model explor role drainag activity, encapsulation, macrophag toler bacillari load qualiti immun respons lesions' pattern interstiti resid alveolar macrophages, activ macrophages, neutrophils, intracellular bacilli, grow non grow extracellular bacilli, dormant bacilli, fibroblast 2,3,4,6,7,8,9,10, 11 [15] convect diffus partial differenti equat evalu efficaci anti il10 anti il 13 treatment m0, m1 m2 macrophages, infect macrophages, extracellular intracellular bacilli dendrit cells, th1 th2 cells, naiv cd4+ t cells, cytokin (il1, il 2, il10, il12, il13, ifn tnf, gmcsf) 3,5,6 [18] multi compartmen t hybrid model (includ abm, pdes, odes) ye studi antigen presentation, t cell priming, differenti traffick context tb granuloma format macrophages, t cells, bacilli, cytokin chemokines, dendrit cell 3,5,6 [21] multi compartmen t hybrid model (includ abm, pdes, odes) ye explor properti ln environment conditions, t cell antigen affect amount type memori t cells, success vaccin agspecif nave t cells, central memori t cells, effector memori t cells, dendrit cells, effector cells, macrophages, bacilli, chemokines, cytokines, solubl ligand 3,5,6 [22] integr multiscal model demonstr hypoxia occur human respons granuloma format macrophag t cell particles, oxygen, chemokines; cytokin bacilli field variabl 3,6,14 [23] multiscal hybrid model (includ abm, pdes, odes) ye pair modeling, statist mathemat dataset deriv nonhuman primat studi acceler biomark discoveri macrophages, t cells, bacilli, cytokin chemokin 3,5,6,13 [24] multiscal hybrid model (includ abm, pdes, odes) ye investig regulatori role tgf 1 granulomas' control macrophag (resting, activated, infected, chronic infected), t cell (cytotoxic, inflammatory, regulatory), bacilli, cytokin chemokin 3, 6 [27] multiscal hybrid model (includ abm, pdes, odes) ye elucid dynam lead fibrosi identifi factor distinguish central peripher fibrosi role cytokin cell fibroblasts, myofibroblasts, macrophag (resting, activated, infected, chronic inected), t cell (cytotoxic, inflammatory, regulatory), bacilli, cytokin chemokin (il10, tgf 1, tnf...), collagen 3, 6, 10 [28] multiscal hybrid model (includ abm, pdes, odes) ye address bacteri phenotyp emerg role granuloma dynam predict potenti vitro screen identifi bacteri metabol target treatment tb macrophag (resting, activated, infected, chronic infected), t cell (cytotoxic, inflammatory, regulatory), bacilli, cytokin chemokines, compound (oxygen, glucose, triacylglycerol) 3,6,14 [29] multiscal hybrid model (includ abm, pdes, odes) ye explor role low t cell exhaust tb granuloma macrophag (resting, activated, infected, chronic infected), t cell (cytotoxic, inflammatory, regulatory), bacilli, cytokin chemokin 3,6,14 [30] agentbas model studi role lesion coalesc essenti growth factor activ tb lesions' size, ag posit 4,7,9 [32] nonlinear ordinari differenti equat assess impact competit intracellular extracellular bacteria infect preval noninfect macrophages, infect macrophages, bacilli tcell 3, 6 [33] hybrid cellular automaton investig role bacteri cell state initi bacteri locat (distanc blood vessels) treatment outcom bacilli, macrophag t cells; oxygen, drug chemokin 3,6,14 [34] reaction diffus model offer predict tool character oxygen concentr profil hypoxia necrosi oxygen concentr 8 [41] * figur 1 details: 1. long road alveoli; 2. interact alveoli; 3&4. onset granuloma, prolif (3) exud (4); 5. interact region lymph node; 6&8. control bacillari load prolif granuloma thank predominium th1 response; 7&9. progress extracellular increas bacillari load thank enhanc entranc pmns; 10. encapsul prolif lesions; 11. drainag dormant bacilli insid foami macrophag bronchial tree; 12. drainag gastrointestin tract; 13&14. system reinfect infect lymph node (13) directli lesion (14).